Henry Schein, Inc. HSIC

Revenue Intelligence Report • 48 quarters of SEC filing data • Updated 2026-03-15

SG&A investments drive revenue, with an elasticity of 0.63% in revenue for every 1% change in SG&A, while R&D impact is not quantified in this dataset. The model, based on a log-log specification, shows credible predictive performance with 9.7% MAPE and a holdout error of about 1.1% on a 3.4B quarterly baseline, supported by 48 quarters of data. The FY revenue forecast is about $13B, down 0.9% YoY, signaling a modest revenue decline despite ongoing SG&A activity. For investors, the ROI of SG&A spend appears positive but modest, underscoring the need for spending efficiency and cost discipline given the absence of quantified R&D gains and the modest top-line outlook.

Investment Thesis

At 9.7% MAPE, the model captures Henry Schein, Inc.'s broad revenue trajectory, though quarterly variability suggests sensitivity to external factors. Sales & marketing spend shows a 0.63x elasticity, suggesting effective go-to-market execution.

Next FY Revenue
$13.1B
-0.9% YoY
SG&A Elasticity
0.63x
Model Accuracy
9.7% MAPE
Holdout validation: The model predicted $3.4B vs the actual $3.4B — an error of 1.1%.
Note: Henry Schein, Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

HSIC Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $3.4B $3.4B $2.4B – $4.9B +6.5% ✓ In range
Q1 2026 $3.3B $1.9B – $5.5B +2.7%
Q2 2026 $3.2B $1.7B – $6.1B +0.2%
Q3 2026 $3.3B $1.6B – $6.9B -0.7%
Q4 2026 $3.3B $1.4B – $7.4B -5.4%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Henry Schein, Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.948 -5.2% -5.2% below trend 13
FQ2 (Dec–Feb) 1.1466 +14.7% +14.7% above trend 6
FQ3 (Mar–May) 0.9303 -7.0% -7.0% below trend 13
FQ4 (Jun–Aug) 0.98 -2.0% In line with trend 13

How Spending Drives Revenue

HSIC Spending Timing
Reading this chart: Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

WAT MCK CRL TMO WST DGX GEHC VRTX